Diskussionsleitung: W. Koenig (München), C. Werner (Homburg/Saar)
| (P1139) | Very low high-density lipoprotein-cholesterol and long-term mortality | |
| I. Dykun, S. Hendricks, O. Babinets, F. Al-Rashid, M. Totzeck, T. Rassaf, A.-A. Mahabadi (Essen) | ||
| (P1140) | Sphingosine-1-phosphate (S1P) signaling in aortic aneurysm formation and dissection | |
| N. Schröder, D. A. Duse, K. Kaiser, I. Scheideler, M. Gräler, M. Lainka, P. Keul, B. Levkau (Düsseldorf, Essen, Jena) | ||
| (P1141) | Endothelial cannabinoid receptor CB1 deficiency decreases oxLDL uptake and attenuates vascular inflammation in atherosclerosis | |
| B. Chen, R. Guillamat Prats, G. Li, Y. Jansen, R. Megens, B. Lutz, S. Hofmann, S. Herzig, S. Steffens, für die Studiengruppe: AG Steffens (München, Munich, Mainz, Neuherberg) | ||
| (P1142) | Immunophenotyping for Cardiovascular Risk Stratification in Acute Coronary Syndrome vs. Acute Ischemic Stroke- results from the multicenter prospective BeLOVE cohort study | |
| D. Meteva, T. Gerhardt, O. Schweizerhof, A. Aigner, S. Piper, J. Kollmus-Heege, J. Last, A.-S. Schatz, C. Seppelt, Y. Abdelwahed, B. Juri, N. Kränkel, D. Müller, C. Nolte, M. Endres, U. Landmesser, J. Weber, D. Leistner, für die Studiengruppe: BeLOVE (Berlin) | ||
| (P1143) | The Influence of Lipoprotein(a) on Aortic Valve Calcification in Patients undergoing Transcatheter Aortic Valve Implantation | |
| M. Miller, M. Gercek, J. Gilis-Januszewski, V. Rudolph, K.-P. Mellwig, T. K. Rudolph (Bad Oeynhausen) | ||
| (P1144) | Correlation of Cholesterol Efflux Capacity with Femoral and Carotid Plaque Volume Measured by Sonographic 3D Plaque Volumetry | |
| M. Noflatscher, M. Hunjadi, M. Schreinlechner, S. Philip, P. Deutinger, D. Lener, F. Mair, M. Theurl, R. Kirchmair, A. Bauer, A. Ritsch, P. Marschang (Innsbruck, AT; Bozen, IT) |